Coca-Cola Europacific Partners reports recent share buybacks on multiple exchanges

Published 12/11/2025, 13:34
Coca-Cola Europacific Partners reports recent share buybacks on multiple exchanges

Coca-Cola Europacific Partners plc (NASDAQ:CCEP) reported a series of share repurchases last week as part of its ongoing buyback program. According to a press release statement included in a filing with the U.S. Securities and Exchange Commission, the company purchased its own ordinary shares on various trading venues between November 4 and November 10, 2025. The stock has shown strong momentum recently, with InvestingPro data showing a 9.35% price return over the past week and nearly 23% over the past six months.

The company confirmed it bought back ordinary shares each day on both U.S. and U.K. trading venues. The repurchased shares will be cancelled. The transactions are part of a share buyback program announced on February 14, 2025, under which the company expects to repurchase up to €1 billion of ordinary shares in total. According to InvestingPro analysis, CCEP currently trades slightly above its Fair Value, with a "GOOD" overall Financial Health Score of 2.59 out of 5, suggesting the company remains in solid financial position to continue its buyback program.

Details from the filing show the following aggregate purchases:

  • On November 4, 2025, the company repurchased 75,415 ordinary shares on U.S. trading venues, including NASDAQ, and 34,000 shares across London trading venues.
  • On November 5, 2025, 74,660 shares were repurchased on U.S. trading venues and 34,000 on London trading venues.
  • On November 6, 2025, 73,944 shares were repurchased on U.S. trading venues and 34,000 on London trading venues.
  • On November 7, 2025, 73,606 shares were repurchased on U.S. trading venues and 33,958 on London trading venues.
  • On November 10, 2025, 71,388 shares were repurchased on U.S. trading venues and 32,000 on London trading venues.

The highest price paid per share on U.S. trading venues during this period reached $91.68, while on London venues, the highest price was £69.60. The lowest prices paid were $86.01 in the U.S. and £66.00 in the U.K. CCEP’s current trading price of $27.09 reflects the company’s dual-currency reporting structure, with trading in EUR while financial reporting is done in USD. The stock currently offers a 2.95% dividend yield, although dividend growth declined by 3.89% in the last twelve months.

Coca-Cola Europacific Partners is listed on Euronext Amsterdam, NASDAQ, London Stock Exchange, and the Spanish Stock Exchanges under the symbol CCEP. The company stated that these repurchases are in accordance with its previously announced program and applicable market regulations. Despite a 17.26% price decline over the past year, CCEP has posted impressive revenue growth of 20.29% in the last twelve months. Investors seeking deeper insights into CCEP’s valuation and over 30 additional financial metrics can access them through InvestingPro.

All information is based on a press release statement included in the company’s SEC filing.

In other recent news, Magic Software Enterprises announced that it will release its third-quarter financial results on November 18, 2025. This disclosure was made in a filing with the Securities and Exchange Commission, although no further details about the results or announcement format were provided. Meanwhile, Tribal Rides International has undergone a corporate name change to SUPA Consolidated Inc. and appointed new executive leadership. The change was approved by the board and shareholders and has been filed with the Nevada Secretary of State, with a pending update from FINRA.

Coca-Cola Europacific Partners has continued its share buyback program with recent purchases of ordinary shares on both US and UK trading venues. The company confirmed multiple transactions, all of which will result in the cancellation of the repurchased shares. In acquisition news, UPS has completed its purchase of Andlauer Healthcare Group for USD $1.6 billion. This transaction enhances UPS Healthcare’s cold chain capabilities across North America and globally. These developments reflect ongoing strategic activities across the companies involved.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.